Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Cochlear Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Cochlear Implant (CI) Bionic ear is a device that can be surgically implanted into a person's cochlea to stimulate it to enhance or restore hearing. Cochlear Implants works by directly stimulating any functioning auditory nerve inside the cochlea with electrical impulses.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cochlear Implants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cochlear Implants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cochlear Implants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Cochlear Implants Overview
4 Products under Development
4.1 Cochlear Implants - Pipeline Products by Stage of Development
4.2 Cochlear Implants - Pipeline Products by Segment
4.3 Cochlear Implants - Pipeline Products by Territory
4.4 Cochlear Implants - Pipeline Products by Regulatory Path
4.5 Cochlear Implants - Pipeline Products by Estimated Approval Date
4.6 Cochlear Implants - Ongoing Clinical Trials
5 Cochlear Implants - Pipeline Products under Development by Companies
5.1 Cochlear Implants Companies - Pipeline Products by Stage of Development
5.2 Cochlear Implants – Companies Pipeline Products by Stage of Development
6 Cochlear Implants Companies and Product Overview
6.1 Advanced Bionics AG Company Overview
6.1.1 Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview
6.2 Advanced Bionics LLC Company Overview
6.2.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 Auritec Pharmaceuticals Inc Company Overview
6.3.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview
6.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.5 Cochlear Ltd Company Overview
6.5.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.6 Demant A/S Company Overview
6.6.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
6.7 Hannover Medical School Company Overview
6.7.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
6.8 Huntington Medical Research Institutes Company Overview
6.8.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
6.9 Labyrinth Devices Company Overview
6.9.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
6.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview
6.10.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
6.11 Naval Information Warfare Center Pacific Company Overview
6.11.1 Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview
6.12 Northwestern University Company Overview
6.12.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.13 OtoKinetics Inc Company Overview
6.13.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 Sonova Holding AG Company Overview
6.14.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
6.15 Tel Aviv Sourasky Medical Center Company Overview
6.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.16 Trinity College Dublin Company Overview
6.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
6.17 University of Michigan Pediatric Device Consortium Company Overview
6.17.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
6.18 University of Utah Company Overview
6.18.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
6.19 University of Wisconsin Madison Company Overview
6.19.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
7 Cochlear Implants- Recent Developments
7.1 May 07, 2024: Sonova Announces Management Board Succession
7.2 Feb 07, 2024: Sonova Opens New Operations Facility Serving Americas Region
7.3 Dec 04, 2023: Advanced Bionics Extends Marvel CI Product Offering with Remote Programming and Expanded Linked Two-Ear Solutions
7.4 Nov 21, 2023: Sonova Holding: First Half Results 2023/24
7.5 Aug 24, 2023: Envoy Medical Appoints David R. Wells as Chief Financial Officer
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Cochlear Implants - Pipeline Products by Stage of Development
Table 2: Cochlear Implants - Pipeline Products by Segment
Table 3: Cochlear Implants - Pipeline Products by Territory
Table 4: Cochlear Implants - Pipeline Products by Regulatory Path
Table 5: Cochlear Implants - Pipeline Products by Estimated Approval Date
Table 6: Cochlear Implants - Ongoing Clinical Trials
Table 7: Cochlear Implants Companies - Pipeline Products by Stage of Development
Table 8: Cochlear Implants – Companies Pipeline Products by Stage of Development
Table 9: Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Naida CI Marvel Sound Processor - Product Status
Table 11: Naida CI Marvel Sound Processor - Product Description
Table 12: Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Hires Fidelity 120 Pediatrics - Product Status
Table 14: Hires Fidelity 120 Pediatrics - Product Description
Table 15: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Steroid Eluting Cochlear Implant - Product Status
Table 17: Steroid Eluting Cochlear Implant - Product Description
Table 18: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Cerashield Coated Cochlear Inner Ear Implant - Product Status
Table 20: Cerashield Coated Cochlear Inner Ear Implant - Product Description
Table 21: Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Nucleus Profile Plus - Product Status
Table 23: Nucleus Profile Plus - Product Description
Table 24: Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Neuro 2 - Product Status
Table 26: Neuro 2 - Product Description
Table 27: Demant A/S - Ongoing Clinical Trials Overview
Table 28: Neuro 2 - Pupillometry Techniques Usage to Quantify the Programming Parameters Effect in the Auditory Effort in Zti Opticon Cochlear Implant Adult Users
Table 29: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Optical Cochlea Stimulator - Product Status
Table 31: Optical Cochlea Stimulator - Product Description
Table 32: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Multisite Device - Product Status
Table 34: Multisite Device - Product Description
Table 35: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
Table 36: MVI Vestibular Implant System - Product Status
Table 37: MVI Vestibular Implant System - Product Description
Table 38: Labyrinth Devices - Ongoing Clinical Trials Overview
Table 39: MVI Vestibular Implant System - First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation
Table 40: MVI Vestibular Implant System - Vestibular Implantation in Older Adults
Table 41: MVI Vestibular Implant System - Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
Table 42: MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Totally Implantable Cochlear Implant (TICI) - Product Status
Table 44: Totally Implantable Cochlear Implant (TICI) - Product Description
Table 45: Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Bionic Cochlea Implant - Product Status
Table 47: Bionic Cochlea Implant - Product Description
Table 48: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Cochlear Implant - Product Status(Northwestern University)
Table 50: Cochlear Implant - Product Description(Northwestern University)
Table 51: OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Krescendo I - Product Status
Table 53: Krescendo I - Product Description
Table 54: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Next Generation Cochlear Implant - Product Status
Table 56: Next Generation Cochlear Implant - Product Description
Table 57: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Implant Electrode Extender - Product Status
Table 59: Implant Electrode Extender - Product Description
Table 60: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Closed-loop Cochlear Implant - Product Status
Table 62: Closed-loop Cochlear Implant - Product Description
Table 63: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Enhanced Cochlear Implant Device - Product Status
Table 65: Enhanced Cochlear Implant Device - Product Description
Table 66: University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Microphone Cochlear Implant - Product Status
Table 68: Microphone Cochlear Implant - Product Description
Table 69: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Cochlear Implant - Product Status(University of Wisconsin Madison)
Table 71: Cochlear Implant - Product Description(University of Wisconsin Madison)
Table 72: Glossary
2.2. List of Figures
Figure 1: Cochlear Implants - Pipeline Products by Stage of Development
Figure 2: Cochlear Implants - Pipeline Products by Segment
Figure 3: Cochlear Implants - Pipeline Products by Territory
Figure 4: Cochlear Implants - Pipeline Products by Regulatory Path
Figure 5: Cochlear Implants - Pipeline Products by Estimated Approval Date
Figure 6: Cochlear Implants - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings